Laboratorios Farmaceuticos Rovi SA (ROVI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
46
About the Report
About the Report
Summary
Laboratorios Farmaceuticos Rovi SA (Rovi) is a developer and manufacturer of prescription and hospital products. The company offers hospital products such as Iomeron and Iopamiro, Multihance, Y Prohance, Sonovue, contrast injection systems, Sodium Heparin and Siklos. Its diagnostic products comprise imaging contrast media and contrast injection systems. Rovi's prescription products are used in the treatment of diseases such as osteoporosis, chronic obstructive pulmonary disease, degenerative osteoarthritis, coronary artery disease and chronic heart failure, among others. The company has operations in Italy, the UK, Austria, Ireland, Hungary, Poland, Spain, Portugal and others. Rovi is headquartered in Madrid, Spain.
Laboratorios Farmaceuticos Rovi SA (ROVI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Laboratorios Farmaceuticos Rovi SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratorios Farmaceuticos Rovi SA, Medical Devices Deals, 2012 to YTD 2018 9
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Laboratorios Farmaceuticos Rovi Enters into Agreement with Biogaran 11
Rovi Enters into Co-Marketing Agreement with Novartis for Neparvis 12
Orexigen Therapeutics Enters into Distribution Agreement with Laboratorios Farmaceuticos Rovi 13
Laboratorios Farmaceuticos Rovi Enters into Co-Marketing Agreement with Merck Sharp & Dohme for Orvatez 14
ROVI Enters into Agreement with Astellas to Market Volutsa 15
Rovi Enters Into Agreement With Medice Arzneimittel Putter To Commercialize Medicebran And Medikinet 16
Rovi Enters Into Agreement With Novartis Farma To Market Hirobriz Breezhaler And Ulunar Breezhaler 17
Licensing Agreements 18
Hikma Pharma Enters into Licensing Agreement with Rovi 18
Acquisition 19
Grupo Ferrer Internacional Completes Acquisition Of 50% Stake In Alentia Biotech From Laboratorios Farmaceuticos ROVI 19
Laboratorios Farmaceuticos Rovi SA-Key Competitors 20
Laboratorios Farmaceuticos Rovi SA-Key Employees 21
Laboratorios Farmaceuticos Rovi SA-Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 24
Financial Announcements 24
Jul 26, 2018: ROVI: First half 2018 results 24
Apr 25, 2018: Rovi Reports Operating Revenue Growth of 12% Underpinned by Outstanding Bemiparin Sales 30
Nov 08, 2017: ROVI: Nine-month period ending 30th September 2017 Financial Results 36
Jul 26, 2017: ROVI-First Half 2017 Financial Results 40
Apr 21, 2017: ROVI-First Half 2017 Financial Results 43
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46
List of Figure
List of Figures
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratorios Farmaceuticos Rovi SA, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratorios Farmaceuticos Rovi SA, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratorios Farmaceuticos Rovi SA, Medical Devices Deals, 2012 to YTD 2018 9
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Laboratorios Farmaceuticos Rovi Enters into Agreement with Biogaran 11
Rovi Enters into Co-Marketing Agreement with Novartis for Neparvis 12
Orexigen Therapeutics Enters into Distribution Agreement with Laboratorios Farmaceuticos Rovi 13
Laboratorios Farmaceuticos Rovi Enters into Co-Marketing Agreement with Merck Sharp & Dohme for Orvatez 14
ROVI Enters into Agreement with Astellas to Market Volutsa 15
Rovi Enters Into Agreement With Medice Arzneimittel Putter To Commercialize Medicebran And Medikinet 16
Rovi Enters Into Agreement With Novartis Farma To Market Hirobriz Breezhaler And Ulunar Breezhaler 17
Hikma Pharma Enters into Licensing Agreement with Rovi 18
Grupo Ferrer Internacional Completes Acquisition Of 50% Stake In Alentia Biotech From Laboratorios Farmaceuticos ROVI 19
Laboratorios Farmaceuticos Rovi SA, Key Competitors 20
Laboratorios Farmaceuticos Rovi SA, Key Employees 21
Laboratorios Farmaceuticos Rovi SA, Other Locations 22
Laboratorios Farmaceuticos Rovi SA, Subsidiaries 22
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.